Skip to main content
. 2011 May 30;2011:157073. doi: 10.4061/2011/157073

Table 2.

Prevalence of genetic and epigenetic alteration in the different subtypes of serrated polyps by combining all comparable data from [73, 7584].

Polyp type BRAF mutation KRAS mutation CIMP-H* MLH1 methylation MGMT methylation
HP
 Microvesicular 66.3% 12.3% 47.4% 39.5% 26.3%
 Goblet-cell 20% 48.4% 14.3% 14.3% 0%
 All subtypes 51.5% 22.1% 38.5% 27% 14.8%
SSA/P 83.9% 5.8% 75.9% 42.6% 25%
TSA 62.5% 22.4% 79.3% 47.5% 74.2%

*CIMP-H: high level of CIMP in polyps defined by ≥2/5 methylated markers from O'Brien et al. [76, 85].